Literature DB >> 33135226

Blood transfusion activity in a general hospital during the COVID-19 pandemic.

Karen Marín-Mori1, Isabel González-Gascón Y Marín1, María-Ángeles Foncillas-García1, Carolina Muñoz-Novas1, María Infante1, Juan Churruca-Sarasqueta1, Elena Landete-Hernández1, Begoña Bueno-García2, Mercedes Duffort-Falco3, José-Ángel Hernández-Rivas1,4.   

Abstract

BACKGROUND: The COVID-19 outbreak has affected almost all hospital departments, including transfusion services. However, the demand for transfusions in a general hospital designated to deal with COVID-19 patients has not been analysed before. STUDY DESIGN AND METHODS: A retrospective study was conducted to evaluate blood transfusion practices from 15 March to 14 April 2020 at Hospital Universitario Infanta Leonor (Madrid, Spain). During this month, with few exceptions, the hospital became a 'COVID-19' centre. In addition, transfusion rates during this time frame and the same period over the last 4 years were compared.
RESULTS: From 15 March to 14 April 2020, only 254 blood components were transfused, resulting in a 49·3% reduction over the previous year. Interestingly, in critically ill patients, the red blood cell (RBC) transfusion/bed ratio significantly decreased during this period (0·92) compared to the same ratio over the past 4 years (2·70) (P = 0·02). Of note, 106 blood components (95 RBC; 11 platelet concentrates) were transfused to only 36 out of 1348 COVID-19 patients (2·7%). The main reason for RBC transfusion in COVID-19 patients was a previous underlying disease (44%) followed by bleeding (25%) and inflammatory anaemia (25%).
CONCLUSION: This is the first study to report a decrease in blood transfusions during the COVID-19 pandemic in a general hospital and especially in the intensive care unit. The results of this study suggest that COVID-19 does not generally induce transfusion requiring anaemia, being the main causes for transfusion in these patients underlying conditions or bleeding.
© 2020 International Society of Blood Transfusion.

Entities:  

Keywords:  COVID-19; patient blood management; transfusion

Year:  2020        PMID: 33135226     DOI: 10.1111/vox.13024

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Blood supply, transfusion demand and mortality in Italian patients hospitalised during nine months of COVID-19 pandemic.

Authors:  Elvira Grandone; Mario Mastroianno; Lazzaro di Mauro; Antonella Caroli; Giovanni Tiscia; Angelo Ostuni
Journal:  Blood Transfus       Date:  2021-11-29       Impact factor: 5.752

2.  Blood usage at a large academic center in Maryland in relation to the COVID-19 pandemic in 2020.

Authors:  Colin Murphy; Magali Fontaine; Paul Luethy; Heather McGann; Bryon Jackson
Journal:  Transfusion       Date:  2021-04-26       Impact factor: 3.337

3.  Impact of COVID-19 on Blood Donation and Supply: A Multicenter Cross-Sectional Study from Saudi Arabia.

Authors:  Nora Y Hakami; Afnan J Al-Sulami; Wafaa A Alhazmi; Talal H Qadah; Waleed M Bawazir; Abdullah Y Hamadi; Amani Y Owaidah; Razan A Alhefzi; Fawaz Y Hamdi; Amr Maqnas; Ghassab F Alghassab; Maha A Badawi; Salwa I Hindawi
Journal:  Biomed Res Int       Date:  2022-01-12       Impact factor: 3.411

4.  A Cohort Study in Intensive Care Units: Health Decisions Related to Blood Transfusion during the COVID-19 Pandemic.

Authors:  Raúl Juárez-Vela; José Antonio García-Erce; Vicente Gea-Caballero; Regina Ruiz de Viñaspre-Hernandez; José Ángel Santos-Sánchez; Juan Luis Sánchez-González; Eva María Andrés-Esteban; Michał Czapla; Clara Isabel Tejada; Kapil Laxman Nanwani-Nanwani; Ainhoa Serrano-Lázaro; Manuel Quintana-Díaz
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

5.  Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia.

Authors:  Kevin E Shopsowitz; Christina Lim; Andrew W Shih; Nick Fishbane; Brian R Berry; Mark Bigham; Tanya Petraszko; Jacqueline Trudeau; Maureen Wyatt; Matthew T S Yan; Douglas Morrison
Journal:  Vox Sang       Date:  2021-07-26       Impact factor: 2.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.